126 related articles for article (PubMed ID: 35718239)
21. Deletion of Glycogen Synthase Kinase-3β in D
Li YC; Panikker P; Xing B; Yang SS; Alexandropoulos C; McEachern EP; Akumuo R; Zhao E; Gulchina Y; Pletnikov MV; Urs NM; Caron MG; Elefant F; Gao WJ
Biol Psychiatry; 2020 Apr; 87(8):745-755. PubMed ID: 31892408
[TBL] [Abstract][Full Text] [Related]
22. Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin.
Ochs SM; Dorostkar MM; Aramuni G; Schön C; Filser S; Pöschl J; Kremer A; Van Leuven F; Ovsepian SV; Herms J
Mol Psychiatry; 2015 Apr; 20(4):482-9. PubMed ID: 24912492
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.
Jang HD; Shin JH; Park DR; Hong JH; Yoon K; Ko R; Ko CY; Kim HS; Jeong D; Kim N; Lee SY
J Biol Chem; 2011 Nov; 286(45):39043-50. PubMed ID: 21949120
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
[TBL] [Abstract][Full Text] [Related]
25. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
26. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.
Prickaerts J; Moechars D; Cryns K; Lenaerts I; van Craenendonck H; Goris I; Daneels G; Bouwknecht JA; Steckler T
J Neurosci; 2006 Aug; 26(35):9022-9. PubMed ID: 16943560
[TBL] [Abstract][Full Text] [Related]
27. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
28. Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK-3β in 3xTg-AD mice.
Li W; Wu M; Zhang Y; Wei X; Zang J; Liu Y; Wang Y; Gong CX; Wei W
J Neurochem; 2020 Dec; 155(6):697-713. PubMed ID: 32578216
[TBL] [Abstract][Full Text] [Related]
29. Continuous GSK-3β overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice.
Zhang K; Song X; Xu Y; Li X; Liu P; Sun N; Zhao X; Liu Z; Xie Z; Peng J
J Affect Disord; 2013 Mar; 146(1):45-52. PubMed ID: 23021826
[TBL] [Abstract][Full Text] [Related]
30. Control of neuronal excitability by GSK-3beta: Epilepsy and beyond.
Jaworski T
Biochim Biophys Acta Mol Cell Res; 2020 Sep; 1867(9):118745. PubMed ID: 32450268
[TBL] [Abstract][Full Text] [Related]
31. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
[TBL] [Abstract][Full Text] [Related]
32. GSK-3β regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIα.
Amici M; Lee Y; Pope RJP; Bradley CA; Cole A; Collingridge GL
Eur J Neurosci; 2021 Oct; 54(8):6815-6825. PubMed ID: 32463939
[TBL] [Abstract][Full Text] [Related]
33. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
[TBL] [Abstract][Full Text] [Related]
34. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant effects of creatine on amyloid β
Rosa JM; Pazini FL; Cunha MP; Colla ARS; Manosso LM; Mancini G; Souza ACG; de Bem AF; Prediger RD; Rodrigues ALS
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():270-278. PubMed ID: 29753049
[TBL] [Abstract][Full Text] [Related]
36. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
DaRocha-Souto B; Coma M; Pérez-Nievas BG; Scotton TC; Siao M; Sánchez-Ferrer P; Hashimoto T; Fan Z; Hudry E; Barroeta I; Serenó L; Rodríguez M; Sánchez MB; Hyman BT; Gómez-Isla T
Neurobiol Dis; 2012 Jan; 45(1):425-37. PubMed ID: 21945540
[TBL] [Abstract][Full Text] [Related]
37. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
[TBL] [Abstract][Full Text] [Related]
39. Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling.
Singh S; Mishra A; Bharti S; Tiwari V; Singh J; Parul ; Shukla S
Mol Neurobiol; 2018 Aug; 55(8):6500-6517. PubMed ID: 29327199
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
